ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China · Delayed Price · Currency is CNY

27.65

-0.55 (-1.95%)

Jul 29, 2026, 4:00 PM EDT

ChengDa Pharmaceuticals Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	458.3	406.37	333.13	414.3	411.46	415.73
Revenue Growth	48.54%	21.99%	-19.59%	0.69%	-1.03%	11.44%
Gross Profit	142.93	137.12	125.8	175.37	182.92	200.02
Operating Income	-8.26	-19.13	-69	57.68	70.27	112.08
Net Income	-3.52	-11.93	-28.1	90.98	106.48	100.44
Earnings Per Share	-0.02	-0.08	-0.18	0.59	0.70	0.87
EPS Growth	-	-	-	-16.33%	-18.80%	-17.11%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
China	260.24	223.5	264.94	205.85	194.96
Foreign	146.13	109.63	149.37	205.61	220.76
Total	406.37	333.13	414.3	411.46	415.73

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	964.14	995.88	1,136	1,364	1,381	18.49
Total Debt	59.11	59.11	80.12	-	-	69.06
Net Cash (Debt)	905.02	936.77	1,056	1,364	1,381	-50.56
Net Cash Growth	-9.72%	-11.29%	-22.58%	-1.26%	-	-
Net Cash Per Share	5.98	6.18	6.95	8.82	9.12	-0.44

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	45.57	34.02	28.65	192.07	47.67	83.14
Capital Expenditures	-58.19	-69.02	-286.36	-224.67	-205.69	-138.7
Free Cash Flow	-12.63	-35	-257.72	-32.6	-158.03	-55.56
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	31.19%	33.74%	37.76%	42.33%	44.45%	48.11%
Operating Margin	-1.80%	-4.71%	-20.71%	13.92%	17.08%	26.96%
Pretax Margin	-0.52%	-3.26%	-8.16%	25.16%	29.19%	27.73%
Profit Margin	-0.77%	-2.94%	-8.44%	21.96%	25.88%	24.16%
FCF Margin	-2.76%	-8.61%	-77.36%	-7.87%	-38.41%	-13.36%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Dividend Per Share	0.200	0.200	0.200	0.200	0.188	0.281
Dividend Per Share Growth	0%	0%	0%	6.67%	-33.34%	-
Dividend Yield	0.71%	0.49%	1.00%	0.81%	0.61%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	43.24	46.13	-
PS Ratio	9.14	15.17	9.18	9.50	11.94	-